Apelin delivered by extracellular vesicles to damaged lungs was found to ease PAH in animal models of the disease, per a ...

Columnist Jen Cueva talks with fellow patient Jolie Lizana about her journey to becoming a patient advocate and columnist for ...

A protein called BMPER found at low levels in models has emerged as a PAH treatment target as it may ease disease progression ...

Columnist Anna Jeter is delighted to find themes that are relevant to her life in the fictional narratives of writers and ...

Columnist Colleen Steele says that glimmers are like an antidote to some of the events that spark her caregiving anxiety.

Following the first sale of Yutrepia to treat certain types of PH, Liquidia has received $50 million under its financing ...

A Phase 3 clinical trial testing the experimental daily oral treatment ralinepag in people with PAH has completed enrollment.

PAH patients with cardiovascular disease risk had similar hospitalization and mortality rates as those without after a ...

Adding Winrevair treatment significantly reduced the risk of clinical worsening in people with a recent PAH diagnosis, per a ...

With patient enrollment now complete, topline results are expected early next year from a Phase 3 trial testing PAH treatment seralutinib.

That funding came from Biocurate, a venture led by the University of Melbourne and Monash that aims to help translate promising treatment approaches from the lab into medicines that can be used by ...